GEN Stock Analysis: Gen Digital | NASDAQ
Software - Infrastructure | NASDAQ, USA | Market Cap: 14.730m USD | 12M Return: -10.8% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 170M
EPS Trend: 99.6%
Qual. Beats: 3
Rev. Trend: 91.8%
Qual. Beats: 1
Warnings
Tailwinds
No distinct edge detected
Seasonality 10.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Gen Digital Inc. is a consumer-focused cybersecurity company that provides cyber safety and trust-based solutions for individuals, families, and small businesses. Its offerings span security and performance management, identity protection, online privacy, technology platforms, restoration support, digital reputation management, and secure financial wellness services. The company markets its products under a portfolio of well-known consumer security brands, including Norton, Avast, LifeLock, MoneyLion, Avira, AVG, ReputationDefender, and CCleaner, reflecting a strategy built largely through acquisition.
The company was founded in 1982 and is headquartered in Tempe, Arizona. It was previously known as NortonLifeLock Inc. before rebranding to Gen Digital Inc. in November 2022. It trades on NASDAQ under the ticker symbol GEN and is classified within the Information Technology sector, specifically the Application Software sub-industry. As a cybersecurity software provider, Gen Digital operates primarily on a subscription-based business model, a common structure in the consumer software industry that provides recurring revenue through annual or multi-year product licenses and service plans.
- Direct customer count growth drives recurring subscription revenue
- MoneyLion integration expands fintech and financial wellness revenue
- Heavy debt load pressures margins amid rising interest rates
| Net Income: 973.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.10 > 0.02 and ΔFCF/TA 1.99 > 1.0 |
| NWC/Revenue: -32.58% < 20% (prev -35.76%; Δ 3.18% < -1%) |
| CFO/TA 0.10 > 3% & CFO 1.54b > Net Income 973.0m |
| Net Debt (7.92b) to EBITDA (2.31b): 3.42 < 3 |
| Current Ratio: 0.40 > 1.5 & < 3 |
| Outstanding Shares: last quarter (609.0m) vs 12m ago -2.40% < -2% |
| Gross Margin: 76.28% > 18% (prev 80.28%; Δ -4.00% > 0.5%) |
| Asset Turnover: 32.17% > 50% (prev 25.40%; Δ 6.78% > 0%) |
| Interest Coverage Ratio: 3.20 > 6 (EBIT TTM 1.82b / Interest Expense TTM 569.0m) |
| A: -0.10 (Total Current Assets 1.08b - Total Current Liabilities 2.71b) / Total Assets 15.6b |
| B: 0.02 (Retained Earnings 269.0m / Total Assets 15.6b) |
| C: 0.12 (EBIT TTM 1.82b / Avg Total Assets 15.5b) |
| D: 0.20 (Book Value of Equity 2.61b / Total Liabilities 13.0b) |
| Altman-Z'' = 0.37 = B |
| DSRI: 1.79 (Receivables 423.0m/186.0m, Revenue 5.00b/3.94b) |
| GMI: 1.05 (GM 80.28% / 76.28%) |
| AQI: 1.03 (AQ_t 0.92 / AQ_t-1 0.90) |
| SGI: 1.27 (Revenue 5.00b / 3.94b) |
| TATA: -0.04 (NI 973.0m - CFO 1.54b) / TA 15.6b) |
| Beneish M = -2.12 (Cap -4..+1) = BB |
As of July 04, 2026, the stock is trading at USD 26.67 with a total of 5,151,700 shares traded. Over the past week, the price has changed by +14.41%, over one month by +0.64%, over three months by +38.43% and over the past year by -10.82%.
Current recommended Stop Loss: 24.80 (which is 7% or 1.9 ATR below the current price).
Gen Digital has received a consensus analysts rating of 4.00. Therefore, it is recommended to buy GEN.
- StrongBuy: 4
- Buy: 1
- Hold: 4
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 30 | 12.5% |
P/E Trailing = 15.5732
P/E Forward = 8.0451
P/S = 2.8085
P/B = 5.3818
P/EG = 1.3405
Revenue TTM = 5.00b USD
EBIT TTM = 1.82b USD
EBITDA TTM = 2.31b USD
Long Term Debt = 8.02b USD (from longTermDebt, last quarter)
Short Term Debt = 200.0m USD (from shortTermDebt, last quarter)
Debt = 8.32b USD (from shortLongTermDebtTotal, last quarter) + Leases 64.0m
Net Debt = 7.92b USD (calculated: Debt 8.32b - CCE 402.0m)
Enterprise Value = 22.7b USD (14.7b + Debt 8.32b - CCE 402.0m)
Interest Coverage Ratio = 3.20 (Ebit TTM 1.82b / Interest Expense TTM 569.0m)
EV/FCF = 14.87x (Enterprise Value 22.7b / FCF TTM 1.52b)
FCF Yield = 6.72% (FCF TTM 1.52b / Enterprise Value 22.7b)
FCF Margin = 30.46% (FCF TTM 1.52b / Revenue TTM 5.00b)
Net Margin = 19.46% (Net Income TTM 973.0m / Revenue TTM 5.00b)
Gross Margin = 76.28% ((Revenue TTM 5.00b - Cost of Revenue TTM 1.19b) / Revenue TTM)
Gross Margin QoQ = 74.28% (prev 73.95%)
Tobins Q-Ratio = 1.45 (Enterprise Value 22.7b / Total Assets 15.6b)
Interest Expense / Debt = 6.84% (Interest Expense 569.0m / Debt 8.32b)
Taxrate = 35.61% (538.0m / 1.51b)
NOPAT = 1.17b (EBIT 1.82b * (1 - 35.61%))
Current Ratio = 0.40 (Total Current Assets 1.08b / Total Current Liabilities 2.71b)
Debt / Equity = 3.19 (Debt 8.32b / totalStockholderEquity, last quarter 2.61b)
Debt / EBITDA = 3.42 (Net Debt 7.92b / EBITDA 2.31b)
Debt / FCF = 5.20 (Net Debt 7.92b / FCF TTM 1.52b)
Total Stockholder Equity = 2.44b (last 4 quarters mean from totalStockholderEquity)
RoA = 6.26% (Net Income 973.0m / Total Assets 15.6b)
RoE = 39.86% (Net Income TTM 973.0m / Total Stockholder Equity 2.44b)
RoCE = 17.41% (EBIT 1.82b / Capital Employed (Equity 2.44b + L.T.Debt 8.02b))
RoIC = 9.14% (NOPAT 1.17b / Invested Capital 12.8b)
WACC = 7.78% (E(14.7b)/V(23.1b) * Re(9.69%) + D(8.32b)/V(23.1b) * Rd(6.84%) * (1-Tc(0.36)))
Discount Rate = 9.69% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -64.41 | Cagr: -2.52%
[DCF] Terminal Value 77.97% ; FCFF base≈1.40b ; Y1≈1.60b ; Y5≈2.36b
[DCF] Fair Price = 45.69 (EV 35.4b - Net Debt 7.92b = Equity 27.5b / Shares 602.4m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 99.65 | EPS CAGR: 11.79% | SUE: 2.65 | # QB: 3
Revenue Correlation: 91.78 | Revenue CAGR: 11.10% | SUE: 1.50 | # QB: 1
EPS current Quarter (2026-06-30): EPS=0.69 | Chg30d=+1.47% | Revisions=+12% | Analysts=7
EPS next Quarter (2026-09-30): EPS=0.71 | Chg30d=+1.14% | Revisions=+12% | Analysts=6
EPS current Year (2027-03-31): EPS=2.90 | Chg30d=+1.01% | Revisions=+15% | GrowthEPS=+13.1% | GrowthRev=+7.5%
EPS next Year (2028-03-31): EPS=3.29 | Chg30d=+3.87% | Revisions=+29% | GrowthEPS=+13.5% | GrowthRev=+6.1%
[Analyst] Revisions Ratio: +22% (up=15, down=9)